Clinical trials
Phase 1 Carcinoma, Renal Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Active, not recruiting | 8 |
| Unknown status | 7 |
| Completed | 6 |
| Not yet recruiting | 4 |
| Suspended | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 5 |
| Novartis Pharmaceuticals | 2 |
| Peking Union Medical College Hospital | 2 |
| Shanghai Junshi Bioscience Co., Ltd. | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Affiliated Hospital of Jiangnan University | 1 |
| Alliancells-PuRui Biocience Co., Ltd. | 1 |
| Bayer | 1 |
| Betta Pharmaceuticals Co., Ltd. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 37 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Melanoma | 7 |
| Ovarian Neoplasms | 7 |
| Colorectal Neoplasms | 6 |
| Neoplasm Metastasis | 6 |
| Uterine Cervical Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Carcinoma, Transitional Cell | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.